{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:35:03Z","timestamp":1793046903440,"version":"4.5.0"},"reference-count":75,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Androgenetic alopecia is a multifactorial condition characterized by noticeable hair loss, affecting both men and women and representing a debilitating and chronic disorder that considerably affects the quality of life. Available topical treatments based on minoxidil or finasteride require repeated applications and are associated with a certain number of adverse effects. The challenges associated with current treatments pave the way for the research of new therapeutic strategies, more precise and selective, and capable of providing long-term results. In this context, the present review examines the new proposed formulation strategies to deliver 5-\u03b1-reductase inhibitors in order to obtain a targeted drug delivery, for improving drug retention at the site of action in the hair follicle, contemporaneously reducing drug systemic absorption, which is the cause of important adverse effects. In particular, the research will be focused on the several aspects that influence the performance of nanostructured drug delivery systems in creating a depot in the hair follicles, such as particle size, surface charge, excipients, and combined application with external stimuli (infrared radiation, mechanical massage, ultrasounds application).<\/jats:p>","DOI":"10.3390\/pharmaceutics14020286","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T04:49:51Z","timestamp":1643258991000},"page":"286","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Nanostructured Drug Delivery Systems for Targeting 5-\u03b1-Reductase Inhibitors to the Hair Follicle"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8927-6083","authenticated-orcid":false,"given":"Silvia","family":"Tampucci","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5864-2845","authenticated-orcid":false,"given":"Valentina","family":"Paganini","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0795-2886","authenticated-orcid":false,"given":"Susi","family":"Burgalassi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Chetoni","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7622-4367","authenticated-orcid":false,"given":"Daniela","family":"Monti","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.4065\/80.10.1316","article-title":"Psychological effect, pathophysiology, and management of androgenetic alopecia in men","volume":"80","author":"Stough","year":"2005","journal-title":"Mayo Clin. Proc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/jps.24028","article-title":"Topical formulations containing finasteride. Part I: In vitro permeation\/penetration study and in vivo pharmacokinetics in hairless rat","volume":"103","author":"Monti","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/14740338.2018.1430765","article-title":"Androgenetic alopecia; drug safety and therapeutic strategies","volume":"17","author":"Motofei","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399402005112","article-title":"Androgenetic alopecia: Pathogenesis and potential for therapy","volume":"4","author":"Ellis","year":"2002","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/exd.13373","article-title":"Genetics and other factors in the aetiology of female pattern hair loss","volume":"26","author":"Redler","year":"2017","journal-title":"Exp. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40257-019-00479-x","article-title":"Female Androgenetic Alopecia: An Update on Diagnosis and Manage-ment","volume":"21","author":"Starace","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1523-1747.2003.12615.x","article-title":"Genetic basis of male pattern baldness","volume":"121","author":"Nyholt","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Mercuri, S.R., Paolino, G., Di Nicola, M.R., and Vollono, L. (2021). Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treat-ment for Female Androgenetic Alopecia: Review of the Literature. Medicina, 57.","DOI":"10.3390\/medicina57040311"},{"key":"ref_9","first-page":"5","article-title":"Androgenetic alopecia and current methods of treatment","volume":"14","year":"2005","journal-title":"Acta Dermatovenerol. Alp. Pannonica. Adriat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1097\/GOX.0000000000000005","article-title":"Cause of androgenic alopecia: Crux of the matter","volume":"1","author":"Ustuner","year":"2013","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7770","DOI":"10.12659\/MSM.913116","article-title":"Serum Levels of Androgen-Associated Hormones Are Correlated with Curative Effect in Androgenic Alopecia in Young Men","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/exd.13690","article-title":"A bald statement\u2014Current approaches to manipulate miniaturisation focus only on promoting hair growth","volume":"27","author":"Pantelireis","year":"2018","journal-title":"Exp. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/14656566.2020.1721463","article-title":"A review of the treatment of male pattern hair loss","volume":"21","author":"York","year":"2020","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s13659-020-00267-9","article-title":"A Systemic Review on Topical Marketed Formulations, Natural Products, and Oral Supplements to Prevent Androgenic Alopecia: A Review","volume":"10","author":"Ashique","year":"2020","journal-title":"Nat. Prod. Bioprospect."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jdv.17738","article-title":"Topical Finasteride Study Group. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: A phase III, randomized, controlled clinical trial","volume":"36","author":"Piraccini","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.4155\/tde.14.61","article-title":"Delivery and targeting of nanoparticles into hair follicles","volume":"5","author":"Fang","year":"2014","journal-title":"Ther. Deliv."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2010.11.015","article-title":"Selective follicular targeting by modification of the particle sizes","volume":"150","author":"Patzelt","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2133.2011.10572.x","article-title":"Human hair follicle: Reservoir function and selective targeting","volume":"165","author":"Vogt","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1087-0024.2005.10124.x","article-title":"Follicular targeting\u2014A promising tool in selective dermatotherapy","volume":"10","author":"Vogt","year":"2005","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.jid.5700999","article-title":"Dihydrotestosterone-inducible dickkopf 1 from balding dermal papilla cells causes apoptosis in follicular keratinocytes","volume":"128","author":"Kwack","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"121273","DOI":"10.1016\/j.ijpharm.2021.121273","article-title":"Mapping hair follicle-targeted delivery by particle systems: What has science accom-plished so far?","volume":"610","author":"Costa","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"021014","DOI":"10.1117\/1.3078813","article-title":"Determination of the cuticula thickness of human and porcine hairs and their potential influence on the penetration of nanoparticles into the hair follicles","volume":"14","author":"Lademann","year":"2009","journal-title":"J. Biomed. Opt."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1134\/S1054660X06050033","article-title":"Investigation of differences in follicular penetration of particle- and nonparticle-containing emulsions by laser scanning microscopy","volume":"16","author":"Ossadnik","year":"2006","journal-title":"Laser Phys."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000475473","article-title":"Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia","volume":"30","author":"Roque","year":"2017","journal-title":"Skin Pharmacol. Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41598-019-56760-w","article-title":"Effect of physical stimuli on hair follicle deposition of clobetasol-loaded Lipid Nanocarriers","volume":"10","author":"Angelo","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1208\/s12248-013-9550-y","article-title":"Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells","volume":"16","author":"Aljuffali","year":"2014","journal-title":"AAPS J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1530004","DOI":"10.1142\/S1793545815300049","article-title":"Hair follicles as a target structure for nanoparticles","volume":"8","author":"Lademann","year":"2014","journal-title":"J. Innov. Opt. Health Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.0022-202X.2004.22717.x","article-title":"Penetration profile of microspheres in follicular targeting of terminal hair follicles","volume":"123","author":"Toll","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s11095-009-9919-x","article-title":"Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy","volume":"26","author":"Rancan","year":"2009","journal-title":"Pharm. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4161\/derm.1.4.9501","article-title":"Nanoparticles and their interactions with the dermal barrier","volume":"1","author":"Schneider","year":"2009","journal-title":"Dermatoendo-crinology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jconrel.2005.09.052","article-title":"Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting","volume":"110","author":"Chen","year":"2006","journal-title":"J. Control. Release"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0168-3659(04)00167-1","article-title":"Transdermal delivery of mixnoxidil with block copolymer nanoparticles","volume":"97","author":"Shim","year":"2004","journal-title":"J. Control. Release"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2004.06.015","article-title":"Skin penetration and distribution of polymeric nanoparticles","volume":"99","author":"Naik","year":"2004","journal-title":"J. Control. Release"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/sj.jid.5700226","article-title":"40 nm, but not 750 or 1500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin","volume":"126","author":"Vogt","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1021\/mp9001188","article-title":"Disposition of nanoparticles and an associated lipophilic permeant following topical application to the skin","volume":"6","author":"Wu","year":"2009","journal-title":"Mol. Pharm."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nimb.2007.02.021","article-title":"On the follicular pathway of percutaneous uptake of nanoparticles: Ion microscopy and autoradiography studies","volume":"260","author":"Lekki","year":"2007","journal-title":"Nucl. Instrum. Meth. Phys. Res. B"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/jid.2008.356","article-title":"Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice","volume":"129","author":"Mahe","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000056386","article-title":"The role of follicular penetration. A differential view","volume":"14","author":"Schaefer","year":"2001","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Fresta, M., Mancuso, A., Cristiano, M.C., Urbanek, K., Cilurzo, F., Cosco, D., Iannone, M., and Paolino, D. (2020). Targeting of the Pilosebaceous Follicle by Liquid Crystal Nanocarriers: In Vitro and In Vivo Effects of the Entrapped Minoxidil. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12111127"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Pelikh, O., and Keck, C.M. (2020). Hair Follicle Targeting and Dermal Drug Delivery with Curcumin Drug Nanocrystals\u2014Essential Influ-ence of Excipients. Nanomaterials, 10.","DOI":"10.3390\/nano10112323"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijbiomac.2015.01.036","article-title":"Chitosan nanoparticles for targeting and sustaining minoxidil sulphate delivery to hair follicles","volume":"75","author":"Matos","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1590\/S1984-82502012000400025","article-title":"In vitro skin penetration of clobetasol from lipid nanoparticles: Drug extraction and quantitation in different skin layers","volume":"48","author":"Silva","year":"2012","journal-title":"Braz. J. Pharm. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2006.10.019","article-title":"Nanoparticles\u2014An efficient carrier for drug delivery into the hair follicles","volume":"66","author":"Lademann","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jconrel.2020.09.053","article-title":"Hair follicle targeting with curcumin nanocrystals: Influence of the for-mulation properties on the penetration efficacy","volume":"329","author":"Pelikh","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejps.2016.10.016","article-title":"Solid effervescent formulations as new approach for topical minoxidil delivery","volume":"96","author":"Pereira","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1517\/17425247.2013.776038","article-title":"Drug delivery to hair follicles","volume":"10","author":"Patzelt","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/10717544.2018.1440446","article-title":"Effect of finasteride particle size reduction on its pharmacokinetic, tissue distribution and cellular permeation","volume":"25","author":"Ahmed","year":"2018","journal-title":"Drug Deliv."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijpharm.2014.11.060","article-title":"Improved oral absorption of dutasteride via Soluplus\u00ae-based supersaturable self-emulsifying drug delivery system (S-SEDDS)","volume":"478","author":"Lee","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/jps.24045","article-title":"Topical formulations containing finasteride. Part II: Determination of finasteride penetration into hair follicles using the differential stripping technique","volume":"103","author":"Tampucci","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Bhatia, S. (2016). Nanoparticles Types, Classification, Characterization, Fabrication Methods and Drug Delivery Applications. Natural Polymer Drug Delivery Systems, Springer.","DOI":"10.1007\/978-3-319-41129-3_2"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Terreni, E., Chetoni, P., Tampucci, S., Burgalassi, S., Al-Kinani, A.A., Alany, R.G., and Monti, D. (2020). Assembling Surfactants-Mucoadhesive Polymer Nanomicelles (ASMP-Nano) for Ocular Delivery of Cyclosporine-A. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12030253"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/157341306775473791","article-title":"Liposomes as Vehicles for Enhancing Drug Delivery Via Skin Routes","volume":"2","author":"Fang","year":"2006","journal-title":"Curr. Nanosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2174\/0929867324666171009120154","article-title":"Recent Advances and Perspectives in Liposomes for Cutaneous Drug Delivery","volume":"25","author":"Carita","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Noor, N.M., Abdul-Aziz, A., Sheikh, K., Somavarapu, S., and Taylor, K.M.G. (2020). In Vitro Performance of Dutasteride-Nanostructured Lipid Carriers Coated with Lauric Acid-Chitosan Oligomer for Dermal Delivery. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12100994"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/0883911520913906","article-title":"Development and ex-vivo skin permeation studies of finasteride\u2013poly(lactic acid-co-glycolic acid) and minoxidil\u2013chitosan nanoparticulate systems","volume":"35","author":"Pervaiz","year":"2020","journal-title":"J. Bioact. Compat. Polym."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/17425247.2020.1700226","article-title":"Recent advances in follicular drug delivery of nanoparticles","volume":"17","author":"Patzelt","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.addr.2020.05.011","article-title":"Nanoparticles for topical drug delivery: Potential for skin cancer treatment","volume":"153","author":"Krishnan","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.05.041","article-title":"Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models","volume":"323","author":"Tabbakhian","year":"2006","journal-title":"Int. J. Pharm."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1208\/s12249-008-9124-y","article-title":"In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers","volume":"9","author":"Rao","year":"2008","journal-title":"AAPS Pharmscitech"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejpb.2017.04.012","article-title":"Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery","volume":"117","author":"Noor","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"119709","DOI":"10.1016\/j.ijpharm.2020.119709","article-title":"Novel iron oxide nanocarriers loading finasteride or dutasteride: Enhanced skin penetration for topical treatment of alopecia","volume":"587","author":"Afiune","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1734-1140(12)70901-5","article-title":"Nanoparticles as drug delivery systems","volume":"64","author":"Wilczewska","year":"2012","journal-title":"Pharmacol Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v29.i5.10","article-title":"Liposomes a vesicular nanocarrier: Potential advancements in cancer chemotherapy","volume":"29","author":"Kumar","year":"2012","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"ref_64","unstructured":"Shoukath, A.M., Ateeq, A., Moghis, A., Saifuddin, S., and Ahmad, I. (2008). Lipid Based Pharmaceutical Preparations for Oral and TopiCal Application; Their Compositions, Methods, and Uses. (WO 2,010,036,947 A2), Thereof. Patent."},{"key":"ref_65","unstructured":"Hasson, V., and Castiglioni, M. (2019). Topical Formulations for Treating Dermatological Disorders Including Male Pattern. (WO 2,019,084,503 A1), Baldness. Patent."},{"key":"ref_66","unstructured":"Nam, K. (2019). Nanoliposome-Microbubble Assembly Encapsulating Hair Loss Treatment Drug and Composition Comprising Same for Alleviation or Treatment of Hair. (WO 2,019,245,142 A1), Loss. Patent."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/10837450701481181","article-title":"Development of liposomal systems of finasteride for topical applications: Design, characterization, and in vitro evaluation","volume":"12","author":"Kumar","year":"2007","journal-title":"Pharm. Dev. Technol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"16143","DOI":"10.1039\/D0NR03357J","article-title":"Co-loading of finasteride and baicalin in phospholipid vesicles tailored for the treatment of hair disorders","volume":"12","author":"Caddeo","year":"2020","journal-title":"Nanoscale"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejps.2013.11.008","article-title":"Chitosan-decorated polystyrene-b-poly(acrylic acid) polymersomes as novel carriers for topical delivery of finasteride","volume":"52","author":"Caon","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijbiomac.2020.02.143","article-title":"Dutasteride nanocapsules for hair follicle targeting: Effect of chitosan-coating and physical stimulus","volume":"151","author":"Ushirobira","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2147\/IJN.S296793","article-title":"Physicochemical Characterization of Finasteride Nanosystem for Enhanced Topical Delivery","volume":"16","author":"Irfan","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"ref_72","unstructured":"El-Tamimy, M. (2017). Pharmaceutical. (WO 2,017,096,427 A1), Formulation. Patent."},{"key":"ref_73","unstructured":"Mailland, F., and Mura, E. (2010). Film-Forming Liquid Formulations for Drug Release to Hair and. (WO 2,010,015,556 A1), Scalp. Patent."},{"key":"ref_74","unstructured":"Ahn, B.K., Ko, K.S., Park, S.H., Ki, M.H., and Lim, J.L. (2016). Pharmaceutical Composition Comprising 5alpha-Reductase. (WO 2,016,013,829 A1), Inhibitor. Patent."},{"key":"ref_75","unstructured":"Venkatraman, S., Seah, X.Y., Lim, S.G., Thng, T.G., and Boey, Y.C.F. (2018). An Injectable Composition for Localized Controlled and Sustained Delivery. (WO 2,018,070,940 A1), System. Patent."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/2\/286\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:07:59Z","timestamp":1760134079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/2\/286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":75,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["pharmaceutics14020286"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14020286","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]}}}